Compounds > platinum
Page last updated: 2024-08-22

platinum and Epithelial Neoplasms

platinum has been researched along with Epithelial Neoplasms in 64 studies

Research

Studies (64)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (1.56)18.2507
2000's5 (7.81)29.6817
2010's54 (84.38)24.3611
2020's4 (6.25)2.80

Authors

AuthorsStudies
Antonarelli, G; Catania, C; Conforti, F; Corti, C; Curigliano, G; De Pas, T; Lo Russo, G; Manglaviti, S; Perrino, M; Salvini, P; Varano, GM; Zucali, PA1
Cheng, X; Fan, F; Fei, W; Gu, J; Qin, J; Shen, S; Shen, T; Wu, X; Zhang, T1
Besse, B; Di Maio, M; Facchinetti, F; Hendriks, LEL; Hochstenbag, M; Marcuse, F; Remon, J; Tiseo, M; Villacampa, G1
Elzarkaa, AA; Malik, E; Soliman, AA1
Carter, CA; Cottrill, HM; Oronsky, B; Ray, CM; Spira, AI; Trepel, JB1
Ebbesson, A; Hartman, L; Hedenfalk, I; Jönsson, JM; Malander, S; Martín de la Fuente, L; Måsbäck, A; Nilbert, M1
Chen, Y; Teng, NNH; Westhoff, GL1
Armenia, J; Bagnoli, M; Baldassarre, G; Belletti, B; Benevol, S; Califano, D; Canzonieri, V; Chiappetta, G; D'Andrea, S; Dall'Acqua, A; Giorda, G; Mezzanzanica, D; Militello, L; Pellarin, I; Pellizzari, I; Schiappacassi, M; Sonego, M; Sorio, R1
Bañuelos-Ramírez, JL; Cantón-Romero, JC; Carrillo-Ibarra, S; Castellanos-González, JA; Miranda-Díaz, AG; Rodríguez-Carrizalez, AD; Sifuentes-Franco, S1
Banerjee, S; Birrer, MJ; Colombo, N; Malek, K; Moore, KN; Oaknin, A; Oza, A; Pautier, P; Vergote, I1
Hashimoto, H; Kontani, K; Mimura, M; Miyatake, T; Nagamatsu, M; Nishikawa, A; Takeda, M; Yokoi, T1
Nagao, S1
Aust, S; Cacsire Castillo-Tong, D; Dudek, G; Grimm, C; Horvat, R; Pils, D; Pils, S; Polterauer, S; Reinthaller, A; Schmid, B; Speiser, P1
Bodnar, L; Grala, B; Kozlowski, W; Smoter, M; Stec, R; Szczylik, C; Zieniuk, K1
Benbrook, DM; Hines, L; McCumber, M; Moore, KN; Moxley, KM; Premkumar, P; Queimado, L; Thavathiru, E; Thompson, D; Zuna, RE1
Ferrari, F; Gadducci, A; Landoni, F; Peiretti, M; Perrone, F; Sartori, E; Tana, R1
Bagnoli, M; Canevari, S; De Cecco, L; Granata, A; Iorio, E; Mezzanzanica, D; Nicoletti, R; Pisanu, ME; Podo, F; Ricci, A; Tinaglia, V1
Cui, H; Li, XP; Liu, BJ; Wang, JL; Wang, SJ; Wei, LH; Zhang, G1
Hu, P; Kang, S; Li, Y; Qi, BL; Wang, N; Zhou, RM1
Hasegawa, K; Ichikawa, R; Kato, R; Kawamura, K; Oe, S; Torii, Y; Udagawa, Y1
Butow, P; Donovan, H; Friedlander, ML; Gillies, K; King, MT; Martyn, J; O'Connell, R; Oza, A; Sjoquist, K; Stockler, M; Voysey, M1
Berton-Rigaud, D; Fabbro, M; Favier, L; Lesoin, A; Lortholary, A; Mari, V; Pujade-Lauraine, E; Ray-Coquard, I; Selle, F; Sevin, E1
Asano, T; Hirohashi, Y; Kuroda, T; Mariya, T; Mizuuchi, M; Saito, T; Sato, N; Sonoda, T; Torigoe, T; Yasuda, K1
Li, L; Shi, L; Wang, Q; Yu, H; Zhang, W1
Brachova, P; Button, AM; Carlson, MJ; Dai, D; Devor, EJ; Goodheart, MJ; Leslie, KK; Mott, SL; Mueting, SR; Thiel, KW1
Jansaka, N; Suprasert, P1
Baldwin, PJ; Brenton, JD; Cooke, SL; Earl, HM; Gale, D; Jimenez-Linan, M; Markowetz, F; Murtaza, M; Newman, S; Ng, CK; Parkinson, CA; Piskorz, AM; Rosenfeld, N; Sala, E; Sayal, K; Schwarz, RF; Temple, J1
Kaye, SB; Tan, DS1
Chen, DT; Chen, Z; Cheng, JQ; Fulp, WJ; Georgeades, C; Lancaster, JM; Magliocco, A; Permuth-Wey, J; Reid, BM1
Chang, Y; Chang, YH; Chuang, CM; Lee, WH; Lu, CH; Peng, CW1
Anchora, LP; Fagotti, A; Petrillo, M; Scambia, G1
Chen, C; Chen, J; Jia, XB; Liu, Y; Wang, HJ; Xu, P; Yang, LY1
Almorsy, W; Elshebeiny, M1
Feng, Y; Li, B; Li, S; Miao, Y; Yan, Q1
Li, L; Wang, Q; Wu, WJ; Zhang, W1
Bae, DS; Baek, SY; Choi, CH; Choi, HJ; Kim, BG; Kim, TJ; Lee, JW; Lee, YY; Paik, ES; Shim, M; Sohn, I1
Allen, AR; Bell-McGuinn, KM; Brenton, JD; Coleman, RL; Cragun, JM; Floquet, A; Giordano, H; Goble, S; Harding, TC; Harrell, MI; Isaacson, J; Kaufmann, SH; Konecny, GE; Kristeleit, RS; Leary, A; Lin, KK; Ma, L; Maloney, L; Mann, E; McNeish, IA; O'Malley, DM; Oaknin, A; Oza, AM; Raponi, M; Ray-Coquard, I; Rolfe, L; Scott, CL; Sun, J; Swisher, EM; Tinker, AV; Yelensky, R1
Broggini, M; Caiola, E; Ceppi, L; Damia, G; Ganzinelli, M; Garassino, MC; Guffanti, F; Marabese, M; Piva, S; Rulli, E1
Guan, Z; Jiang, W; Li, G; Li, Y; Liu, Y; Shen, Y; Tan, J; Wang, J; Wang, L; Wang, Z; Wu, F; Wu, J; Xu, Q; Yang, T1
May, MJ; Wharry, CE1
Barbieri, P; Brienza, S; Carminati, P; Colombo, N; du Bois, A; Frigerio, L; Guastalla, JP; Katsaròs, D; Lhommé, C; Lissoni, AA; Parma, G; Pecorelli, S; Poveda, A; Ray-Coquard, I; Tisi, G; Tredan, O; Vermorken, JB1
Del Conte, G; Sessa, C1
Aghajanian, CA; Barakat, RR; Bell-McGuinn, KM; Bhatia, J; Gallagher, DJ; Kauff, ND; Konner, JA; Offit, K; Sabbatini, P; Spriggs, DR1
Clamp, AR; Evans, S; Griffiths, RW; Hasan, J; Jayson, GC; Kumaran, GC; Mitchell, CL; Welch, RS; Zee, YK1
Begent, RH; Boxer, GM; Elmasry, K; Maclean, AB; Morris, RW; Rashid, M; Siddiqui, GK; Wong te Fong, A1
Buss, I; Galanski, MS; Garmann, D; Jaehde, U; Kalayda, GV; Keppler, BK; Weber, G1
Markman, M1
Foretová, L; Fridrichová, P; Laco, J; Melichar, B; Papajík, T; Simkovič, M1
Bischofs, E; Eichbaum, M; Eickhoff, R; Fehm, T; Fersis, N; Fricke, HC; Gebauer, G; Lenz, F; Mayer, C; Schmidt, M; Schneeweiss, A; Sohn, C; Solomayer, E; Wallwiener, M1
Hai-Yan, S; Na, W; Rong-Miao, Z; Shan, K; Shu-Ying, Y; Yan, L; Yip, BH1
Enomoto, T; Kim, A; Naka, T; Ueda, Y1
Aoki, D; Chiyoda, T; Kataoka, F; Nomura, H; Susumu, N; Tominaga, E; Tsuda, H; Yamagami, W1
Boran, N; Celik, B; Hizli, D; Isikdogan, Z; Karabuk, E; Kose, MF; Tulunay, G; Turan, T; Yilmaz, S1
Altınbaş, SK; Boran, N; Celik, B; Hızlı, D; Köse, MF; Turan, T; Yılmaz, S1
Connor, JP; Felder, M; Kapur, A; Onujiogu, N1
Blank, S; Boyd, L; Czok, S; Eberhardt, S; Lee, SJ; Muggia, F; Muller, CY; Pothuri, B; Rutledge, T; Verschraegen, CF1
Buyukberber, S; Elkiran, ET; Gumusay, O; Inal, A; Isikdogan, A; Kaplan, MA; Kucukoner, M; Ozdemir, N; Ulas, A; Unal, O; Urakci, Z; Yaman, S1
Conner, M; Dobbin, ZC; Han, HD; Katre, AA; Landen, CN; Lopez-Berestein, G; Nowsheen, S; Shah, MM; Sood, AK; Steg, AD; Yang, ES; Ziebarth, AJ1
Biason, P; Campagnutta, E; Giorda, G; Lucia, E; Stopar, A; Talamini, R; Toffoli, G; Visentin, M1
Ahn, SE; Bazer, FW; Chung, HH; Han, JY; Jeong, W; Kim, HS; Kim, J; Kim, MA; Kim, MK; Kim, YB; Lim, W; Song, G; Song, YS1
Baron, M; Blanchot, J; Bonnier, P; Castaigne, D; Classe, JM; Duvillard, P; Leblanc, E; Lhommé, C; Morice, P; Querleu, D; Rey, A1
Angioli, R; Basile, S; Bellati, F; Benedetti Panici, P; De Vivo, A; Manci, N; Muzii, L; Perniola, G1
Plaxe, SC1
Christian, MC; Trimble, EL; Wright, J1

Reviews

5 review(s) available for platinum and Epithelial Neoplasms

ArticleYear
Immune checkpoint blockers in patients with unresectable or metastatic thymic epithelial tumours: A meta-analysis.
    European journal of cancer (Oxford, England : 1990), 2023, Volume: 180

    Topics: Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Humans; Immune Checkpoint Inhibitors; Neoplasms, Glandular and Epithelial; Platinum; Thymoma; Thymus Neoplasms

2023
A brief review of the management of platinum-resistant-platinum-refractory ovarian cancer.
    Medical oncology (Northwood, London, England), 2017, Volume: 34, Issue:6

    Topics: Antineoplastic Agents; Carcinoma, Ovarian Epithelial; Cisplatin; Drug Resistance, Neoplasm; Female; Humans; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Platinum

2017
Chemotherapy for Patients with BRCA1 and BRCA2-Mutated Ovarian Cancer: Same or Different?
    American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting, 2015

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; BRCA1 Protein; BRCA2 Protein; Carcinoma, Ovarian Epithelial; Drug Resistance, Neoplasm; Female; Humans; Molecular Targeted Therapy; Mutation; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Platinum; Poly(ADP-ribose) Polymerase Inhibitors; Prognosis; Treatment Outcome

2015
Therapeutic strategies in epithelial ovarian cancer.
    Journal of experimental & clinical cancer research : CR, 2012, Feb-13, Volume: 31

    Topics: Bridged-Ring Compounds; Carcinoma, Ovarian Epithelial; Combined Modality Therapy; Disease-Free Survival; Drug Resistance, Neoplasm; Female; Humans; Molecular Targeted Therapy; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Peritoneal Neoplasms; Platinum; Prognosis; Taxoids

2012
Treatment of platinum-resistant ovarian cancer.
    Expert opinion on pharmacotherapy, 2001, Volume: 2, Issue:8

    Topics: Animals; Antineoplastic Agents; Clinical Trials as Topic; Drug Resistance, Neoplasm; Drug Therapy, Combination; Female; Humans; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Platinum; Quality of Life

2001

Trials

6 trial(s) available for platinum and Epithelial Neoplasms

ArticleYear
FORWARD I: a Phase III study of mirvetuximab soravtansine versus chemotherapy in platinum-resistant ovarian cancer.
    Future oncology (London, England), 2018, Volume: 14, Issue:17

    Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Ovarian Epithelial; Drug Resistance, Neoplasm; Female; Follow-Up Studies; Humans; Immunoconjugates; Maytansine; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Platinum; Prognosis; Survival Rate

2018
A phase II study of lenalidomide in platinum-sensitive recurrent ovarian carcinoma.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2014, Volume: 25, Issue:11

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; CA-125 Antigen; Carcinoma, Ovarian Epithelial; Disease-Free Survival; Drug-Related Side Effects and Adverse Reactions; Fallopian Tube Neoplasms; Female; Humans; Lenalidomide; Membrane Proteins; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Platinum; Thalidomide

2014
Rucaparib in relapsed, platinum-sensitive high-grade ovarian carcinoma (ARIEL2 Part 1): an international, multicentre, open-label, phase 2 trial.
    The Lancet. Oncology, 2017, Volume: 18, Issue:1

    Topics: Aged; Antineoplastic Agents; BRCA1 Protein; BRCA2 Protein; Carcinoma, Ovarian Epithelial; Drug Resistance, Neoplasm; Fallopian Tube Neoplasms; Female; Follow-Up Studies; Germ-Line Mutation; Humans; Indoles; International Agencies; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Peritoneal Neoplasms; Platinum; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Prognosis; Prospective Studies; Salvage Therapy; Survival Rate

2017
Phase II of oral gimatecan in patients with recurrent epithelial ovarian, fallopian tube or peritoneal cancer, previously treated with platinum and taxanes.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2010, Volume: 21, Issue:4

    Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Chemotherapy, Adjuvant; Fallopian Tube Neoplasms; Female; Humans; Middle Aged; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Peritoneal Neoplasms; Platinum; Recurrence; Taxoids

2010
The PACOVAR-trial: a phase I/II study of pazopanib (GW786034) and cyclophosphamide in patients with platinum-resistant recurrent, pre-treated ovarian cancer.
    BMC cancer, 2011, Oct-20, Volume: 11

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Ovarian Epithelial; Cyclophosphamide; Drug Resistance, Neoplasm; Female; Humans; Indazoles; Neoplasm Recurrence, Local; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Platinum; Pyrimidines; Sulfonamides

2011
Phase II study of bevacizumab with liposomal doxorubicin for patients with platinum- and taxane-resistant ovarian cancer.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2012, Volume: 23, Issue:12

    Topics: Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibiotics, Antineoplastic; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Bridged-Ring Compounds; Carcinoma, Ovarian Epithelial; Disease-Free Survival; Doxorubicin; Drug Resistance, Neoplasm; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Platinum; Taxoids; Treatment Outcome

2012

Other Studies

53 other study(ies) available for platinum and Epithelial Neoplasms

ArticleYear
Continuous sunitinib schedule in advanced platinum refractory thymic epithelial neoplasms: A retrospective analysis from the ThYmic MalignanciEs (TYME) Italian collaborative group.
    European journal of cancer (Oxford, England : 1990), 2022, Volume: 174

    Topics: Humans; Indoles; Neoplasms, Glandular and Epithelial; Platinum; Pyrroles; Retrospective Studies; Sunitinib; Thymoma; Thymus Neoplasms; Treatment Outcome

2022
High co-expression of SLC7A11 and GPX4 as a predictor of platinum resistance and poor prognosis in patients with epithelial ovarian cancer.
    BJOG : an international journal of obstetrics and gynaecology, 2022, Volume: 129 Suppl 2

    Topics: Amino Acid Transport System y+; Carcinoma, Ovarian Epithelial; Drug Resistance, Neoplasm; Female; Humans; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Phospholipid Hydroperoxide Glutathione Peroxidase; Platinum; Prognosis; Retrospective Studies

2022
Epithelial Ovarian Cancer and Cancer Stem Cells.
    Advances in experimental medicine and biology, 2021, Volume: 1330

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Ovarian Epithelial; Drug Resistance, Neoplasm; Female; Humans; Neoplasm Recurrence, Local; Neoplasms, Glandular and Epithelial; Neoplastic Stem Cells; Ovarian Neoplasms; Platinum

2021
Claudin-4 Expression is Associated With Survival in Ovarian Cancer But Not With Chemotherapy Response.
    International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists, 2018, Volume: 37, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; BRCA1 Protein; BRCA2 Protein; Carcinoma; Carcinoma, Ovarian Epithelial; Claudin-4; Cohort Studies; Disease-Free Survival; Drug Resistance, Neoplasm; Female; Humans; Immunohistochemistry; Kaplan-Meier Estimate; Middle Aged; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Platinum; Prognosis; Sweden; Tissue Array Analysis

2018
Targeting Foxm1 Improves Cytotoxicity of Paclitaxel and Cisplatinum in Platinum-Resistant Ovarian Cancer.
    International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2017, Volume: 27, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Ascites; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Cisplatin; Drug Resistance, Neoplasm; Drug Synergism; Female; Forkhead Box Protein M1; Humans; Molecular Targeted Therapy; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Platinum; RNA, Messenger; Thiostrepton

2017
CDK6 protects epithelial ovarian cancer from platinum-induced death via FOXO3 regulation.
    EMBO molecular medicine, 2017, Volume: 9, Issue:10

    Topics: Animals; Antineoplastic Agents; Ataxia Telangiectasia Mutated Proteins; Carcinoma, Ovarian Epithelial; Cell Death; Cell Line, Tumor; Cyclin-Dependent Kinase 6; DNA Damage; Female; Forkhead Box Protein O3; Humans; Mice; Mice, Nude; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Piperazines; Platinum; Primary Cell Culture; Protein Kinase Inhibitors; Pyridines; Survival Analysis; Xenograft Model Antitumor Assays

2017
Markers of Oxidative Stress and Inflammation in Ascites and Plasma in Patients with Platinum-Sensitive, Platinum-Resistant, and Platinum-Refractory Epithelial Ovarian Cancer.
    Oxidative medicine and cellular longevity, 2017, Volume: 2017

    Topics: Adult; Aged; Antioxidants; Ascites; Biomarkers, Tumor; Carcinoma, Ovarian Epithelial; Drug Resistance, Neoplasm; Female; Humans; Inflammation; Interleukin-6; Isoprostanes; Lipid Peroxides; Middle Aged; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Oxidative Stress; Platinum; Tumor Necrosis Factor-alpha

2017
Retrospective analysis of the survival benefit of chemotherapy for recurrent or advanced epithelial ovarian carcinoma in patients previously treated with paclitaxel plus platinum-based chemotherapy.
    European journal of gynaecological oncology, 2016, Volume: 37, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Ovarian Epithelial; Disease-Free Survival; Humans; Neoplasm Staging; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Paclitaxel; Platinum; Retrospective Studies

2016
[Ⅲ.Surgery for Platinum Sensitive Recurrent Epithelial Ovarian Cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2019, Volume: 46, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Ovarian Epithelial; Female; Humans; Neoplasm Recurrence, Local; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Platinum

2019
Expression of Bcl-2 and the antiapoptotic BAG family proteins in ovarian cancer.
    Applied immunohistochemistry & molecular morphology : AIMM, 2013, Volume: 21, Issue:6

    Topics: Adaptor Proteins, Signal Transducing; Adult; Aged; Antineoplastic Agents; Apoptosis Regulatory Proteins; Bridged-Ring Compounds; Carcinoma, Ovarian Epithelial; DNA-Binding Proteins; Female; Humans; Immunohistochemistry; Middle Aged; Multivariate Analysis; Neoplasm Staging; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Platinum; Prognosis; Proto-Oncogene Proteins c-bcl-2; Survival Analysis; Taxoids; Transcription Factors

2013
Tau protein as a potential predictive marker in epithelial ovarian cancer patients treated with paclitaxel/platinum first-line chemotherapy.
    Journal of experimental & clinical cancer research : CR, 2013, Apr-30, Volume: 32

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoma, Ovarian Epithelial; Female; Gene Expression; Humans; Middle Aged; Neoplasm Staging; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Paclitaxel; Platinum; Prognosis; tau Proteins; Treatment Outcome

2013
The role of single nucleotide polymorphisms of the ERCC1 and MMS19 genes in predicting platinum-sensitivity, progression-free and overall survival in advanced epithelial ovarian cancer.
    Gynecologic oncology, 2013, Volume: 130, Issue:2

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma, Ovarian Epithelial; Disease-Free Survival; DNA-Binding Proteins; Drug Resistance, Neoplasm; Endonucleases; Female; Genome-Wide Association Study; Genotype; Humans; Middle Aged; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Platinum; Polymorphism, Single Nucleotide; Transcription Factors

2013
Analysis of failures and clinical outcome of advanced epithelial ovarian cancer in patients with microscopic residual disease at second-look reassessment following primary cytoreductive surgery and first-line platinum-based chemotherapy.
    European journal of gynaecological oncology, 2013, Volume: 34, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Ovarian Epithelial; Female; Humans; Middle Aged; Neoplasm, Residual; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Platinum; Retrospective Studies; Second-Look Surgery; Treatment Failure; Treatment Outcome

2013
Choline kinase-alpha by regulating cell aggressiveness and drug sensitivity is a potential druggable target for ovarian cancer.
    British journal of cancer, 2014, Jan-21, Volume: 110, Issue:2

    Topics: Carcinoma, Ovarian Epithelial; Cell Death; Cell Line, Tumor; Cell Movement; Cell Proliferation; Choline; Choline Kinase; Down-Regulation; Doxorubicin; Female; Humans; Lipid Metabolism; Molecular Targeted Therapy; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Paclitaxel; Phosphorylcholine; Platinum; RNA Interference; Signal Transduction; Transcriptome

2014
Oxaliplatin-based combination chemotherapy is still effective for the treatment of recurrent and platinum-resistant epithelial ovarian cancer: results from a single center.
    Chinese medical journal, 2013, Volume: 126, Issue:23

    Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Ovarian Epithelial; Drug Resistance, Neoplasm; Drug Therapy, Combination; Female; Humans; Middle Aged; Neoplasms, Glandular and Epithelial; Organoplatinum Compounds; Ovarian Neoplasms; Oxaliplatin; Platinum; Retrospective Studies

2013
[Polymorphisms of ERCC1 gene and outcomes in epithelial ovarian cancer patients with platinum-based chemotherapy].
    Zhonghua fu chan ke za zhi, 2013, Volume: 48, Issue:11

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoma, Ovarian Epithelial; Disease-Free Survival; DNA Repair; DNA-Binding Proteins; Drug Resistance, Neoplasm; Endonucleases; Female; Genotype; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Platinum; Polymorphism, Single Nucleotide; Prognosis; Young Adult

2013
Retrospective comparative study of irinotecan and pegylated liposomal doxorubicin for platinum-resistant or -refractory epithelial ovarian and primary peritoneal carcinoma.
    Archives of gynecology and obstetrics, 2014, Volume: 290, Issue:5

    Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Camptothecin; Carcinoma; Carcinoma, Ovarian Epithelial; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Drug Resistance, Neoplasm; Female; Humans; Irinotecan; Kaplan-Meier Estimate; Middle Aged; Neoplasms, Glandular and Epithelial; Neutropenia; Ovarian Neoplasms; Peritoneal Neoplasms; Platinum; Polyethylene Glycols; Retrospective Studies; Salvage Therapy; Treatment Outcome

2014
Symptom burden and outcomes of patients with platinum resistant/refractory recurrent ovarian cancer: a reality check: results of stage 1 of the gynecologic cancer intergroup symptom benefit study.
    International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2014, Volume: 24, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Ovarian Epithelial; Drug Resistance, Neoplasm; Fallopian Tube Neoplasms; Female; Follow-Up Studies; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Palliative Care; Peritoneal Neoplasms; Platinum; Prognosis; Quality of Life; Severity of Illness Index; Surveys and Questionnaires

2014
Prognostic impact of human leukocyte antigen class I expression and association of platinum resistance with immunologic profiles in epithelial ovarian cancer.
    Cancer immunology research, 2014, Volume: 2, Issue:12

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Ovarian Epithelial; Drug Resistance, Neoplasm; Female; Gene Expression Regulation, Neoplastic; Histocompatibility Antigens Class I; Humans; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Platinum; Prognosis; Risk Factors

2014
[Establishment and biological characteristics of a platinum-resistance nude mouse model in epithelial ovarian cancer].
    Zhonghua fu chan ke za zhi, 2014, Volume: 49, Issue:7

    Topics: Animals; Antineoplastic Agents; Apoptosis; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Cell Proliferation; Cisplatin; DNA Repair; Drug Resistance, Neoplasm; Female; Genes, BRCA1; Humans; Mice; Mice, Nude; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Platinum

2014
TP53 oncomorphic mutations predict resistance to platinum‑ and taxane‑based standard chemotherapy in patients diagnosed with advanced serous ovarian carcinoma.
    International journal of oncology, 2015, Volume: 46, Issue:2

    Topics: Adult; Aged; Bridged-Ring Compounds; Carcinoma, Ovarian Epithelial; Cystadenocarcinoma, Serous; Disease-Free Survival; Drug Resistance, Neoplasm; Female; Humans; Middle Aged; Mutation; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Platinum; Prognosis; Taxoids; Tumor Suppressor Protein p53

2015
Survival outcomes of recurrent epithelial ovarian cancer: experience from a Thailand northern tertiary care center.
    Asian Pacific journal of cancer prevention : APJCP, 2014, Volume: 15, Issue:24

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Ovarian Epithelial; Cystadenocarcinoma, Serous; Drug Resistance, Neoplasm; Female; Follow-Up Studies; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Paclitaxel; Platinum; Prognosis; Retrospective Studies; Survival Rate; Tertiary Care Centers

2014
Spatial and temporal heterogeneity in high-grade serous ovarian cancer: a phylogenetic analysis.
    PLoS medicine, 2015, Volume: 12, Issue:2

    Topics: Aged; Algorithms; Alleles; Carcinoma, Ovarian Epithelial; Disease-Free Survival; DNA, Neoplasm; Drug Resistance, Neoplasm; Female; Genetic Variation; Humans; Middle Aged; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Phylogeny; Platinum

2015
STAT3 polymorphisms may predict an unfavorable response to first-line platinum-based therapy for women with advanced serous epithelial ovarian cancer.
    International journal of cancer, 2016, Feb-01, Volume: 138, Issue:3

    Topics: Carcinoma, Ovarian Epithelial; Case-Control Studies; Cystadenocarcinoma, Serous; Female; Humans; Middle Aged; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Platinum; Polymorphism, Single Nucleotide; Receptor, Notch1; STAT3 Transcription Factor

2016
Second-Line Intraperitoneal Chemotherapy for Recurrent Epithelial Ovarian, Tubal and Peritoneal Cancer: A Propensity Score-Matching Study.
    Chemotherapy, 2016, Volume: 61, Issue:5

    Topics: Aged; Antineoplastic Agents; Carcinoma, Ovarian Epithelial; Databases, Factual; Disease-Free Survival; Female; Humans; Injections, Intraperitoneal; Kaplan-Meier Estimate; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Peritoneal Neoplasms; Platinum; Propensity Score

2016
Cytoreductive Surgery Plus Platinum-Based Hyperthermic Intraperitoneal Chemotherapy in Epithelial Ovarian Cancer: A Promising Integrated Approach to Improve Locoregional Control.
    The oncologist, 2016, Volume: 21, Issue:5

    Topics: Carcinoma, Ovarian Epithelial; Combined Modality Therapy; Cytoreduction Surgical Procedures; Female; Humans; Hyperthermia, Induced; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Platinum

2016
[Expression of MiR-130a in Serum Samples of Patients with Epithelial Ovarian Cancer and Its Association with Platinum Resistance].
    Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition, 2016, Volume: 47, Issue:1

    Topics: Apoptosis; Carcinoma, Ovarian Epithelial; Drug Resistance, Neoplasm; Female; Humans; MicroRNAs; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Platinum; Proto-Oncogene Proteins c-bcl-2; PTEN Phosphohydrolase

2016
Gemcitabine-oxaliplatin (GEMOX) for epithelial ovarian cancer patients resistant to platinum-based chemotherapy.
    Journal of the Egyptian National Cancer Institute, 2016, Volume: 28, Issue:3

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Ovarian Epithelial; Deoxycytidine; Disease-Free Survival; Drug Resistance, Neoplasm; Female; Gemcitabine; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Glandular and Epithelial; Organoplatinum Compounds; Ovarian Neoplasms; Oxaliplatin; Platinum

2016
Neutrophil to lymphocyte ratio and platelet to lymphocyte ratio are predictive of chemotherapeutic response and prognosis in epithelial ovarian cancer patients treated with platinum-based chemotherapy.
    Cancer biomarkers : section A of Disease markers, 2016, Jun-07, Volume: 17, Issue:1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Blood Platelets; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Female; Humans; Leukocyte Count; Lymphocytes; Middle Aged; Neoplasm Grading; Neoplasm Staging; Neoplasms, Glandular and Epithelial; Neutrophils; Ovarian Neoplasms; Platelet Count; Platinum; Prognosis; Proportional Hazards Models; Retrospective Studies; ROC Curve; Treatment Outcome

2016
[Identification and prognostic value of differentially expressed proteins of patients with platinum resistance epithelial ovarian cancer in serum].
    Zhonghua fu chan ke za zhi, 2016, Jul-25, Volume: 51, Issue:7

    Topics: Biomarkers, Tumor; Carcinoma, Ovarian Epithelial; China; Computational Biology; Cystadenocarcinoma, Serous; Disease-Free Survival; Drug Resistance, Neoplasm; Female; Humans; Kaplan-Meier Estimate; Neoplasm Recurrence, Local; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Platinum; Prognosis; Proteomics; ROC Curve; Treatment Outcome

2016
Nomograms Predicting Platinum Sensitivity, Progression-Free Survival, and Overall Survival Using Pretreatment Complete Blood Cell Counts in Epithelial Ovarian Cancer.
    Cancer research and treatment, 2017, Volume: 49, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Blood Cell Count; Carcinoma, Ovarian Epithelial; Drug Resistance, Neoplasm; Female; Follow-Up Studies; Humans; Middle Aged; Neoplasm Grading; Neoplasm Staging; Neoplasms, Glandular and Epithelial; Nomograms; Ovarian Neoplasms; Platinum; Prognosis; Retrospective Studies; Survival Analysis; Treatment Outcome; Young Adult

2017
The 5'UTR variant of ERCC5 fails to influence outcomes in ovarian and lung cancer patients undergoing treatment with platinum-based drugs.
    Scientific reports, 2016, 12-14, Volume: 6

    Topics: 5' Untranslated Regions; Aged; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Carcinoma, Ovarian Epithelial; DNA-Binding Proteins; Endonucleases; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasms, Glandular and Epithelial; Nuclear Proteins; Ovarian Neoplasms; Pharmacogenomic Variants; Platinum; Polymorphism, Genetic; Survival Analysis; Transcription Factors; Treatment Outcome

2016
Platinums sensitize human epithelial tumor cells to lymphotoxin alpha by inhibiting NFkappaB-dependent transcription.
    Cancer biology & therapy, 2008, Volume: 7, Issue:9

    Topics: Antineoplastic Agents; Caspase 3; Cell Line, Tumor; Drug Synergism; Enzyme Activation; HeLa Cells; Humans; Lymphotoxin-alpha; Neoplasms, Glandular and Epithelial; NF-kappa B; Platinum; Prohibitins; Transcription, Genetic

2008
Raising the price of platinum: inhibition of NFkappaB in human tumor epithelial cells.
    Cancer biology & therapy, 2008, Volume: 7, Issue:9

    Topics: Antineoplastic Agents; Apoptosis; Cell Death; Cell Line, Tumor; Clinical Trials as Topic; Drug Synergism; Humans; Lymphotoxin-alpha; Models, Biological; Neoplasms, Glandular and Epithelial; NF-kappa B; Platinum

2008
Targeted therapies: tailored treatment for ovarian cancer: are we there yet?
    Nature reviews. Clinical oncology, 2010, Volume: 7, Issue:2

    Topics: Antineoplastic Agents; Bridged-Ring Compounds; Disease-Free Survival; Drug Resistance, Neoplasm; Female; Humans; Neoplasm Recurrence, Local; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Platinum; Taxoids; Treatment Outcome

2010
Survival in epithelial ovarian cancer: a multivariate analysis incorporating BRCA mutation status and platinum sensitivity.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2011, Volume: 22, Issue:5

    Topics: Antineoplastic Agents; BRCA1 Protein; BRCA2 Protein; Carcinoma, Ovarian Epithelial; Disease-Free Survival; Female; Genetic Association Studies; Humans; INDEL Mutation; Kaplan-Meier Estimate; Middle Aged; Multivariate Analysis; Neoplasm Staging; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Platinum

2011
Outcomes after multiple lines of chemotherapy for platinum-resistant epithelial cancers of the ovary, peritoneum, and fallopian tube.
    International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2011, Volume: 21, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bridged-Ring Compounds; CA-125 Antigen; Carcinoma; Carcinoma, Ovarian Epithelial; Cisplatin; Cytotoxins; Deoxycytidine; Disease-Free Survival; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Fallopian Tube Neoplasms; Female; Gemcitabine; Humans; Kaplan-Meier Estimate; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Paclitaxel; Peritoneal Neoplasms; Platinum; Polyethylene Glycols; Prognosis; Proportional Hazards Models; Retrospective Studies; Survival Analysis; Taxoids; Treatment Outcome

2011
Immunohistochemical expression of VEGF predicts response to platinum based chemotherapy in patients with epithelial ovarian cancer.
    Angiogenesis, 2011, Volume: 14, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Ovarian Epithelial; Demography; Female; Humans; Immunohistochemistry; Kaplan-Meier Estimate; Middle Aged; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Platinum; Treatment Outcome; Vascular Endothelial Growth Factor A; Young Adult

2011
Enhancing lipophilicity as a strategy to overcome resistance against platinum complexes?
    Journal of inorganic biochemistry, 2011, Volume: 105, Issue:5

    Topics: Antineoplastic Agents; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Cell Survival; Cisplatin; DNA; Drug Resistance, Neoplasm; Endocytosis; Humans; Ligands; Neoplasms, Glandular and Epithelial; Organoplatinum Compounds; Ovarian Neoplasms; Platinum

2011
Role of chemotherapy in epithelial ovarian cancer.
    Minerva ginecologica, 2011, Volume: 63, Issue:3

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bridged-Ring Compounds; Carcinoma, Ovarian Epithelial; Female; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Platinum; Taxoids

2011
Therapy-related myeloid neoplasms in epithelial ovarian cancer patients carrying BRCA1 mutation: report of two cases.
    Acta oncologica (Stockholm, Sweden), 2012, Volume: 51, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ovarian Epithelial; Cystadenocarcinoma, Serous; Fatal Outcome; Female; Genes, BRCA1; Heterozygote; Humans; Leukemia, Myeloid, Acute; Middle Aged; Mutation; Neoplasms, Glandular and Epithelial; Neoplasms, Second Primary; Ovarian Neoplasms; Paclitaxel; Platinum

2012
Association between polymorphisms of ERCC1 and survival in epithelial ovarian cancer patients with chemotherapy.
    Pharmacogenomics, 2012, Volume: 13, Issue:4

    Topics: Adult; Biomarkers, Pharmacological; Carcinoma, Ovarian Epithelial; China; DNA-Binding Proteins; Endonucleases; Female; Genotype; Humans; Middle Aged; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Platinum; Polymorphism, Genetic; Prognosis; Survival Analysis

2012
Retrospective study comparing irinotecan and pegylated liposomal doxorubicin in treatment of recurrent platinum-refractory/resistant epithelial ovarian cancer.
    European journal of gynaecological oncology, 2012, Volume: 33, Issue:1

    Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Camptothecin; Carcinoma, Ovarian Epithelial; Disease-Free Survival; Doxorubicin; Drug Resistance, Neoplasm; Female; Hand-Foot Syndrome; Humans; Irinotecan; Kaplan-Meier Estimate; Middle Aged; Mucositis; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Platinum; Polyethylene Glycols; Retrospective Studies; Salvage Therapy

2012
Secondary cytoreductive surgery outcomes of selected patients with paclitaxel/platinum sensitive recurrent epithelial ovarian cancer.
    Journal of surgical oncology, 2012, Sep-15, Volume: 106, Issue:4

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; CA-125 Antigen; Carcinoma, Ovarian Epithelial; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Paclitaxel; Platinum; Treatment Outcome

2012
Best predictors of survival outcome after tertiary cytoreduction in patients with recurrent platinum-sensitive epithelial ovarian cancer.
    European journal of obstetrics, gynecology, and reproductive biology, 2012, Volume: 163, Issue:1

    Topics: Adult; Aged; Carcinoma, Ovarian Epithelial; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasm, Residual; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Platinum; Prognosis; Retrospective Studies; Survival Analysis; Treatment Outcome

2012
DcR3 binds to ovarian cancer via heparan sulfate proteoglycans and modulates tumor cells response to platinum with corresponding alteration in the expression of BRCA1.
    BMC cancer, 2012, May-14, Volume: 12

    Topics: Antineoplastic Agents; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Drug Resistance, Neoplasm; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Genes, BRCA1; Heparan Sulfate Proteoglycans; Humans; Ligands; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Platinum; Protein Binding; Receptors, Tumor Necrosis Factor, Member 6b

2012
Oral etoposide for platinum-resistant and recurrent epithelial ovarian cancer: a study by the Anatolian Society of Medical Oncology.
    Asian Pacific journal of cancer prevention : APJCP, 2012, Volume: 13, Issue:8

    Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Carcinoma, Ovarian Epithelial; Etoposide; Female; Humans; Male; Medical Oncology; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Platinum; Prognosis; Retrospective Studies; Salvage Therapy; Survival Rate

2012
Endoglin (CD105) contributes to platinum resistance and is a target for tumor-specific therapy in epithelial ovarian cancer.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2013, Jan-01, Volume: 19, Issue:1

    Topics: Animals; Antigens, CD; Antineoplastic Agents; Carcinoma, Ovarian Epithelial; Cell Survival; Disease Models, Animal; DNA Damage; DNA Repair; Drug Resistance, Neoplasm; Endoglin; Female; Gene Expression Regulation, Neoplastic; Humans; Mice; Mice, Nude; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Platinum; Receptors, Cell Surface; RNA Interference

2013
Polymorphic thymidylate synthase gene impacts on overall survival of patients with epithelial ovarian cancer after platinum-based chemotherapy.
    Pharmacogenomics, 2012, Volume: 13, Issue:14

    Topics: Adult; Age Factors; Aged; Aged, 80 and over; Biomarkers, Pharmacological; Carcinoma, Ovarian Epithelial; Female; Follow-Up Studies; Genetic Association Studies; Genotype; Humans; Kaplan-Meier Estimate; Middle Aged; Neoplasm Staging; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Platinum; Prognosis; Thymidylate Synthase

2012
SERPINB3 in the chicken model of ovarian cancer: a prognostic factor for platinum resistance and survival in patients with epithelial ovarian cancer.
    PloS one, 2012, Volume: 7, Issue:11

    Topics: 3' Untranslated Regions; Adult; Aged; Aged, 80 and over; Animals; Antigens, Neoplasm; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Cell Transformation, Neoplastic; Chickens; Disease Models, Animal; Disease-Free Survival; Drug Resistance, Neoplasm; Female; Gene Expression Regulation, Neoplastic; Humans; Middle Aged; Neoplasm Staging; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Ovary; Platinum; Prognosis; Serine Proteinase Inhibitors; Serpins

2012
Conservative treatment in epithelial ovarian cancer: results of a multicentre study of the GCCLCC (Groupe des Chirurgiens de Centre de Lutte Contre le Cancer) and SFOG (Société Francaise d'Oncologie Gynécologique).
    Human reproduction (Oxford, England), 2005, Volume: 20, Issue:5

    Topics: Adolescent; Adult; Antineoplastic Agents; Female; Fertility; Follow-Up Studies; Humans; Hysterectomy; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Ovary; Platinum; Pregnancy; Retrospective Studies; Survival Rate

2005
Secondary cytoreductive surgery in patients with platinum-sensitive recurrent ovarian cancer.
    Annals of surgical oncology, 2007, Volume: 14, Issue:3

    Topics: Adenocarcinoma, Clear Cell; Adenocarcinoma, Mucinous; Cystadenocarcinoma, Serous; Endometrial Neoplasms; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Glandular and Epithelial; Observation; Ovarian Neoplasms; Platinum; Prognosis; Prospective Studies

2007
Ovarian cancer.
    Medical Section proceedings : the ... annual Meeting of the Medical Section of the American Council of Life Insurance. American Council of Life Insurance. Medical Section. Meeting, 1994

    Topics: Female; Humans; Neoplasm Metastasis; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Paclitaxel; Platinum; Survival Rate; United States

1994